- Mitchell DH, Sorrell TC, Allworth AM, et al. Ciyptococcal disease of the CNS in immunocompetent hosts - influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995; 20: 611-6.
- Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus necformans. Clin Infect Dis 1995; 21: 28-34.
- Chen S, Sorrell T, Nimmo G, et al Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Clin Infect Dis 2000; 31: 499-508.
- Littmann ML, Walter JE. Cryptococcosis: Current status. Am J Med 1968; 45: 922-32,
- Ellis DH, Pfeiffer TJ. Natural habitat of Cryptococcus neoformans var. gattii. J Clin Microbiol 1990; 28: 1642-4.
- Casadevall A. Antibody immunity and invasive fungal infections. Infect Immunol 1995; 63: 4211-8.
- Gutierrez F, Shi Fu Y, Lurie GU. Cryptococcosis Wstologically resembling histoplasmosis. Arch Pathol 1975; 99: 347-51.
- Gordonson J, Birnbaum W, Jacobson G, et al Pulmonary cryptococcosis. Radiology 1974; 112: 557-61.
- Huffnagle GB, Yates JL, Lipscomb MF. Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4 + and CDS + T cells. / Exp Mod 1991; 173: 793-800.
- Kozel TR. Role of the capsule in phagocytosis of Cryptococcus neoformans. Rev Infect Dis 1988; 10(Suppl 2): s436-9.
- Bulmer GS. Cryptococcus neoformans II. Phagocytosis by human leukocytes. J Bacterial 1967; 94: 1480-3.
- Vecchiarelli A, Pietrella D, Dottorini M, et al Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages. Clin Exp Immunol 1994; 98: 217-23.
- Collins HL, Bancroft GJ. Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses. Infect Immunol 1991; 59: 3883-8.
- Delfino D, Cianci L, MigliardoM, et al. Tumor necrosis factorinducing activities of Cryptococcus neoformans components. Infect Immun 1996; 64: 5199-204.
- Levitz SM. Macrophage-Cryptococcus interactions. Immunol Ser 1994; 6ft 533-43.
- Vecchiarelli A, Retini C, Pietrella D, et ai Downregulation by cryptoccccal polysaccharide of tumor necrosis factor alpha and interleuldn-1-beta secretion from human monocytes. Infect Immunol 1995; 63: 2919-23.
- Kozel TR, Mastroianni RP. Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis. Infect Immunol 1976; 14: 62-7.
- Kozel TR, Pfrommer GS. Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast. Infect Immunol 1986; 52: 1-5.
- Young BJ, Kozel TR. Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans. Infect Immunol 1993; 61: 2966-72.
- Saag MS. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans - response. Clin Infect Dis 1995; 21: 35-6.
- Speed BR, Strawbridge L, Ellis DH. Cryptococcus neoformans van gattii meningitis in an Australian patient with AIDS. J Med Vet Mycol 1993; 31: 395-9.
- Choose new content alerts to be informed about new research of interest to you
- Easy remote access to your institution's subscriptions on any device, from any location
- Save your searches and schedule alerts to send you new results
- Export your search results into a .csv file to support your research